202 related articles for article (PubMed ID: 23326178)
1. Somatic second-hit mutations leads to polycystic liver diseases.
Banales JM; Munoz-Garrido P; Bujanda L
World J Gastroenterol; 2013 Jan; 19(1):141-3. PubMed ID: 23326178
[TBL] [Abstract][Full Text] [Related]
2. Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.
Janssen MJ; Waanders E; Te Morsche RH; Xing R; Dijkman HB; Woudenberg J; Drenth JP
Gastroenterology; 2011 Dec; 141(6):2056-2063.e2. PubMed ID: 21856269
[TBL] [Abstract][Full Text] [Related]
3. Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p.
Waanders E; Croes HJ; Maass CN; te Morsche RH; van Geffen HJ; van Krieken JH; Fransen JA; Drenth JP
Histochem Cell Biol; 2008 Mar; 129(3):301-10. PubMed ID: 18224332
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.
Janssen MJ; Salomon J; Te Morsche RH; Drenth JP
PLoS One; 2012; 7(11):e50324. PubMed ID: 23209713
[TBL] [Abstract][Full Text] [Related]
5. Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.
Cnossen WR; Maurits JS; Salomon J; Te Morsche RH; Waanders E; Drenth JP
J Clin Lab Anal; 2016 Sep; 30(5):431-6. PubMed ID: 26365003
[TBL] [Abstract][Full Text] [Related]
6. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
Waanders E; te Morsche RH; de Man RA; Jansen JB; Drenth JP
Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835903
[TBL] [Abstract][Full Text] [Related]
7. Isolated polycystic liver disease genes define effectors of polycystin-1 function.
Besse W; Dong K; Choi J; Punia S; Fedeles SV; Choi M; Gallagher AR; Huang EB; Gulati A; Knight J; Mane S; Tahvanainen E; Tahvanainen P; Sanna-Cherchi S; Lifton RP; Watnick T; Pei YP; Torres VE; Somlo S
J Clin Invest; 2017 May; 127(5):1772-1785. PubMed ID: 28375157
[TBL] [Abstract][Full Text] [Related]
8. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.
Li A; Davila S; Furu L; Qian Q; Tian X; Kamath PS; King BF; Torres VE; Somlo S
Am J Hum Genet; 2003 Mar; 72(3):691-703. PubMed ID: 12529853
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.
Wills ES; Cnossen WR; Veltman JA; Woestenenk R; Steehouwer M; Salomon J; Te Morsche RH; Huch M; Hehir-Kwa JY; Banning MJ; Pfundt R; Roepman R; Hoischen A; Drenth JP
Eur J Hum Genet; 2016 Dec; 24(12):1707-1714. PubMed ID: 27552964
[TBL] [Abstract][Full Text] [Related]
10. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
Drenth JP; Tahvanainen E; te Morsche RH; Tahvanainen P; Kääriäinen H; Höckerstedt K; van de Kamp JM; Breuning MH; Jansen JB
Hepatology; 2004 Apr; 39(4):924-31. PubMed ID: 15057895
[TBL] [Abstract][Full Text] [Related]
11. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
Schönauer R; Sierks D; Boerrigter M; Jawaid T; Caroff L; Audrezet MP; Friedrich A; Shaw M; Degenhardt J; Forberger M; de Fallois J; Bläker H; Bergmann C; Gödiker J; Schindler P; Schlevogt B; Müller RU; Berg T; Patterson I; Griffiths WJ; Sayer JA; ; Popp B; Torres VE; Hogan MC; Somlo S; Watnick TJ; Nevens F; Besse W; Cornec-Le Gall E; Harris PC; Drenth JPH; Halbritter J
Gastroenterology; 2024 May; 166(5):902-914. PubMed ID: 38101549
[TBL] [Abstract][Full Text] [Related]
12. Genetics of polycystic liver diseases.
Lee-Law PY; van de Laarschot LFM; Banales JM; Drenth JPH
Curr Opin Gastroenterol; 2019 Mar; 35(2):65-72. PubMed ID: 30652979
[TBL] [Abstract][Full Text] [Related]
13. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
Wills ES; Te Morsche RHM; van Reeuwijk J; Horn N; Geomini I; van de Laarschot LFM; Mans DA; Ueffing M; Boldt K; Drenth JPH; Roepman R
Hum Mol Genet; 2017 Nov; 26(21):4190-4202. PubMed ID: 28973524
[TBL] [Abstract][Full Text] [Related]
14. Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.
Waanders E; Lameris AL; Op den Camp HJ; Pluk W; Gloerich J; Strijk SP; Drenth JP
J Proteome Res; 2008 Jun; 7(6):2490-5. PubMed ID: 18419150
[TBL] [Abstract][Full Text] [Related]
15. Genetics and mechanisms of hepatic cystogenesis.
van de Laarschot LFM; Drenth JPH
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1491-1497. PubMed ID: 28782656
[TBL] [Abstract][Full Text] [Related]
16. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
Cornec-Le Gall E; Torres VE; Harris PC
J Am Soc Nephrol; 2018 Jan; 29(1):13-23. PubMed ID: 29038287
[TBL] [Abstract][Full Text] [Related]
17. Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63.
Waanders E; Venselaar H; te Morsche RH; de Koning DB; Kamath PS; Torres VE; Somlo S; Drenth JP
Clin Genet; 2010 Jul; 78(1):47-56. PubMed ID: 20095989
[TBL] [Abstract][Full Text] [Related]
18. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.
Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N
JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801
[TBL] [Abstract][Full Text] [Related]
19. Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease.
Janssen MJ; Waanders E; Woudenberg J; Lefeber DJ; Drenth JP
J Hepatol; 2010 Mar; 52(3):432-40. PubMed ID: 20138683
[TBL] [Abstract][Full Text] [Related]
20. Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.
Boerrigter MM; Duijzer R; Te Morsche RHM; Drenth JPH
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
